Gilead Sciences (GILD) is a large capitalization pharmaceutical and biotechnology company best known for its HIV and HCV (hepatitis C) therapies.
After Gilead showed it could generate large amounts of revenue from new, highly effective cures for HCV, its stock price rose to a peak of $123.57 per share in June 2015. That was quite a climb upward from $37.16 per share at the beginning of 2013, but since then the stock price, although volatile, has drifted mainly downward.
Harvoni pill. Source: Gilead.com
Many analysts and financial journalists, including this author,....More>>>